Metraipolis › archive › dc_f2a03071aedb

Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer — Europe PMC PMID:42155177

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42155177
DOI: 10.1016/j.neo.2026.101318
License (as archived): solo-consultazione
Archived: 2026-11-01T14:25:11.497Z
SHA-256 of the archived text: c47d589e9ccd9acf9232e19662917fa6bdda6b38a539950fc4b6b7cb6a051e7d
Stable URL of this page: https://metraipolis.com/documento/dc_f2a03071aedb

How to cite

Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer — Europe PMC PMID:42155177 — Europe PMC (en), https://europepmc.org/article/MED/42155177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2a03071aedb (Metraipolis archive dc_f2a03071aedb, sha256 c47d589e9ccd9acf9232e19662917fa6bdda6b38a539950fc4b6b7cb6a051e7d)

BibTeX

@misc{dcf2a03071aedb,
  title = {Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer — Europe PMC PMID:42155177},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42155177},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2a03071aedb; sha256 c47d589e9ccd9acf9232e19662917fa6bdda6b38a539950fc4b6b7cb6a051e7d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42155177. Agents can read the archived copy with the MCP tool read_document.